S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|Intellipharmaceutics to Present at Two Upcoming Investor Conferences (2014/3/4)|
|Intellipharmaceutics -- Amended Form of Proxy for Shareholders Meeting to be Held on March 27, 2014 (2014/3/19)|
|Intellipharmaceutics Announces Proposed Public Offering of Units of Common Shares and Warrants (2013/7/26)|
|Intellipharmaceutics Updates Developments on Its Rexista(TM) Oxycodone Technology (2013/7/15)|
|Intellipharmaceutics Announces Pricing of Public Offering of Common Shares and Warrants ()|
|Intellipharmaceutics Closes Public Offering for US$3.1 Million (2013/7/31)|
|Intellipharmaceutics Announces Third Quarter 2013 Results ()|
|Intellipharmaceutics Announces At-The-Market Offering of Common Shares ()|
|Intellipharmaceutics Receives $3.1 Million From Par Pharmaceuticals, Inc. (2014/2/3)|
|Intellipharmaceutics / Par to Make Immediate Commercial Launch of 15 and 30 mg Generic Focalin XR(R) (2013/11/18)|
Click above to view more mutual fund data and stats for ipci - IntelliPharmaCeutics International, Inc..